The specific aims of the Laboratory Cancer Research Center at the Eppley Institute for Research in Cancer and Allied Diseases are to carry out interdisciplinary research in: 1) cancer cause and prevention aimed at determining the mechanisms of action of chemical carcinogens, including the mechanisms of activation of carcinogens and their interactions with DNA, the role of potential environmental carcinogens in human cancer, the interaction of oncogenes and chemical carcinogens in tumor initiation and promotion, and the role of dietary factors in causing and preventing cancer; 2) molecular and cellular biology , including DNA replication, mechanisms of gene transcription, the mechanisms of action of growth factors and hormones, characterization of growth factor receptors and their signal transduction mechanisms, the role of oncogene expression in cellular differentiation, mechanisms of viral reproduction and oncogene activation, and DNA-protein interactions; and 3) developmental therapeutics, including characterization of tumor markers, isolation and characterization of tumor-associated antigens, development of monoclonal antibodies, development of antisense and triple helical-forming oligonucleotides to inhibit cancer cell growth, synthesis of novel antineoplastic agents, use of peripheral stem cells and cytokines in bone marrow transplantation, and design of protocols for improved drug delivery and pharmacokinetic analysis of anticancer agents. To achieve these specific aims we have assembled a group of 52 faculty with expertise in chemistry, biochemistry, cell biology, molecular biology, immunology, pathology, virology, pharmacology, toxicology, nutrition, and clinical oncology. In support of this research we have established core laboratory facilities in animal care, cell culture, histology, molecular biology including 2-dimensional gel electrophoresis, mass spectrometry, nuclear magnetic resonance spectrometry, computer services including molecular modeling and DNA and protein data base analysis, drug analysis and pharmacokinetics, microbial mutagenesis, glassware washing, and safety. In addition, we have established a Leukemia/Lymphoma Tissue Procurement Service that supports a region-wide program for data collection and protocol standardization. The Core Grant faculty also comprise the nucleus of our Cancer Biology Training Program for the education and research training of predoctoral and postdoctoral students.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA036727-11
Application #
2089154
Study Section
Cancer Center Support Review Committee (CCS)
Project Start
1984-07-01
Project End
1995-07-31
Budget Start
1994-09-01
Budget End
1995-07-31
Support Year
11
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of Nebraska Medical Center
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
City
Omaha
State
NE
Country
United States
Zip Code
68198
Won, Harim I; Schulze, Thomas T; Clement, Emalie J et al. (2018) De novo Assembly of the Burying Beetle Nicrophorus orbicollis (Coleoptera: Silphidae) Transcriptome Across Developmental Stages with Identification of Key Immune Transcripts. J Genomics 6:41-52
Zhou, Jiuli; Zeng, Yongji; Cui, Lian et al. (2018) Zyxin promotes colon cancer tumorigenesis in a mitotic phosphorylation-dependent manner and through CDK8-mediated YAP activation. Proc Natl Acad Sci U S A 115:E6760-E6769
Das, Binita; Neilsen, Beth K; Fisher, Kurt W et al. (2018) A Functional Signature Ontology (FUSION) screen detects an AMPK inhibitor with selective toxicity toward human colon tumor cells. Sci Rep 8:3770
Qazi, Asif Khurshid; Siddiqui, Jawed A; Jahan, Rahat et al. (2018) Emerging therapeutic potential of graviola and its constituents in cancers. Carcinogenesis 39:522-533
Hsu, Alice H; Lum, Michelle A; Shim, Kang-Sup et al. (2018) Crosstalk between PKC? and PI3K/AKT Signaling Is Tumor Suppressive in the Endometrium. Cell Rep 24:655-669
Svechkarev, Denis; Sadykov, Marat R; Bayles, Kenneth W et al. (2018) Ratiometric Fluorescent Sensor Array as a Versatile Tool for Bacterial Pathogen Identification and Analysis. ACS Sens 3:700-708
Contreras, Jacob I; Robb, Caroline M; King, Hannah M et al. (2018) Chemical Genetic Screens Identify Kinase Inhibitor Combinations that Target Anti-Apoptotic Proteins for Cancer Therapy. ACS Chem Biol 13:1148-1152
Qi, Bowen; Crawford, Ayrianne J; Wojtynek, Nicholas E et al. (2018) Indocyanine green loaded hyaluronan-derived nanoparticles for fluorescence-enhanced surgical imaging of pancreatic cancer. Nanomedicine 14:769-780
Berger, Ann M; Kupzyk, Kevin A; Djalilova, Dilorom M et al. (2018) Breast Cancer Collaborative Registry informs understanding of factors predicting sleep quality. Support Care Cancer :
Svechkarev, Denis; Mohs, Aaron M (2018) Organic fluorescent dye-based nanomaterials: Advances in the rational design for imaging and sensing applications. Curr Med Chem :

Showing the most recent 10 out of 1372 publications